(Q54328685)

English

Blinatumomab: a novel agent to treat minimal residual disease in patients with acute lymphoblastic leukemia.

scientific article published in October 2011

Statements

Blinatumomab: a novel agent to treat minimal residual disease in patients with acute lymphoblastic leukemia. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit